Nishimura Makoto, Togawa Osamu, Matsukawa Miho, Shono Takashi, Ochiai Yasutoshi, Nakao Masamitsu, Ishikawa Keiko, Arai Shin, Kita Hiroto
Makoto Nishimura, Osamu Togawa, Miho Matsukawa, Takashi Shono, Yasutoshi Ochiai, Masamitsu Nakao, Keiko Ishikawa, Shin Arai, Hiroto Kita, Department of Gastroenterology, Saitama Medical University, International Medical Center, 1397-1, Yamane, Hidaka, Saitama 350-1298, Japan.
World J Gastrointest Endosc. 2012 Jul 16;4(7):301-5. doi: 10.4253/wjge.v4.i7.301.
Since endoscopic ultrasound (EUS) was developed in the 1990s, EUS has become widely accepted as an imaging tool. EUS is categorized into radial and linear in design. Radial endoscopes provide cross-sectional imaging of the mediastinum, gastrointestinal tract, liver, spleen, kidney, adrenal gland, and pancreas, which has highly accuracy in the T and N staging of esophageal, lung, gastric, rectal, and pancreatic cancer. Tumor staging is common indication of radial-EUS, and EUS-staging is predictive of surgical resectability. In contrast, linear array endoscope uses a side-viewing probe and has advantages in the ability to perform EUS-guides fine needle aspiration (EUS-FNA), which has been established for cytologic diagnosis. For example, EUS-FNA arrows accurate nodal staging of esophageal cancer before surgery, which provides more accurate assessment of nodes than radial-EUS imaging alone. EUS-FNA has been also commonly used for diagnose of pancreatic diseases because of the highly accuracy than US or computed tomography. EUS and EUS-FNA has been used not only for TNM staging and cytologic diagnosis of pancreatic cancer, but also for evaluation of chronic pancreatitis, pancreatic cystic lesions, and other pancreatic masses. More recently, EUS-FNA has developed into EUS-guided fine needle injection including EUS-guided celiac plexus neurolysis, celiac plexus block, and other "interventional EUS" procedures. In this review, we have summarized the new possibilities offered by "interventional EUS".
自20世纪90年代内镜超声(EUS)问世以来,它已被广泛认可为一种成像工具。EUS在设计上分为径向和线性两种。径向内镜可提供纵隔、胃肠道、肝脏、脾脏、肾脏、肾上腺和胰腺的横断面成像,在食管癌、肺癌、胃癌、直肠癌和胰腺癌的T和N分期方面具有很高的准确性。肿瘤分期是径向EUS的常见适应证,EUS分期可预测手术可切除性。相比之下,线性阵列内镜使用侧视探头,在进行EUS引导下细针穿刺抽吸(EUS-FNA)方面具有优势,EUS-FNA已被用于细胞学诊断。例如,EUS-FNA可在术前准确对食管癌进行淋巴结分期,比单独的径向EUS成像能更准确地评估淋巴结。由于EUS-FNA比超声或计算机断层扫描具有更高的准确性,它也常用于胰腺疾病的诊断。EUS和EUS-FNA不仅用于胰腺癌的TNM分期和细胞学诊断,还用于评估慢性胰腺炎、胰腺囊性病变和其他胰腺肿块。最近,EUS-FNA已发展为EUS引导下细针注射,包括EUS引导下腹腔神经丛神经松解术、腹腔神经丛阻滞和其他“介入性EUS”程序。在本综述中,我们总结了“介入性EUS”带来的新可能性。